Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 633
Filtrar
1.
J Surg Res ; 256: 397-403, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-32777556

RESUMEN

BACKGROUND: Several composite measures of neighborhood social vulnerability exist and are used in the health disparity literature. This study assesses the performance of the Social Vulnerability Index (SVI) compared with three similar measures used in the surgical literature: Area Deprivation Index (ADI), Community Needs Index (CNI), and Distressed Communities Index (DCI). There are advantages of the SVI over these other scales, and we hypothesize that it performs equivalently. METHODS: We identified all cholecystectomies at a single, urban, academic hospital over a 9-month period. Cases were considered emergency if the patient presented and underwent surgery during that admission. We geocoded patient's addresses and assigned estimated SVI, ADI, CNI, and DCI. Cutoffs for high versus low social vulnerability were generated using Youden's index, and the scales were compared using multivariable modeling. RESULTS: Overall, 366 patients met inclusion criteria, and the majority (n = 266, 73%) had surgery in the emergency setting. On multivariable modeling, patients with high social vulnerability were more likely to undergo emergency surgery compared with those with low social vulnerability in accordance with all four scales: SVI (OR 3.24, P < 0.001), ADI (OR 3.2, P < 0.001), CNI (OR 1.90, P = 0.04), and DCI (OR 2.01, P = 0.03). The scales all had comparable predictive value. CONCLUSIONS: The SVI performs similarly to other indices of neighborhood vulnerability in demonstrating disparities between emergency and elective surgery and is readily available and updated. Because the SVI has multiple subcategories in addition to the overall measure, it can be used to stratify by modifiable factors such as housing or transportation to inform interventions.


Asunto(s)
Procedimientos Quirúrgicos Electivos/estadística & datos numéricos , Tratamiento de Urgencia/estadística & datos numéricos , Disparidades en Atención de Salud/estadística & datos numéricos , Características de la Residencia/estadística & datos numéricos , Poblaciones Vulnerables/estadística & datos numéricos , Centros Médicos Académicos/economía , Centros Médicos Académicos/estadística & datos numéricos , Adulto , Colecistectomía/economía , Colecistectomía/estadística & datos numéricos , Procedimientos Quirúrgicos Electivos/economía , Tratamiento de Urgencia/economía , Femenino , Disparidades en Atención de Salud/economía , Hospitales Urbanos/economía , Hospitales Urbanos/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
2.
Health Serv Res ; 55(4): 524-530, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32196656

RESUMEN

OBJECTIVE: To evaluate whether out-of-pocket (OOP) costs reduced HIV pre-exposure prophylaxis (PrEP) persistence. DATA SOURCE: Participants from five urban community health centers (CHCs) in four US cities enrolled in a PrEP demonstration project from September 2014 to August 2017. STUDY DESIGN: Patients initiating PrEP were followed quarterly until they withdrew from PrEP care or the study ended. Self-reported OOP medication and clinic visit costs were assessed by semiannual questionnaires. Persistence was defined as the time from study enrollment to the last visit after which two subsequent 3-month visits were missed. Multivariable Cox proportional hazard regression was used to assess the effect of demographics, insurance, and OOP costs on PrEP persistence. PRINCIPAL FINDINGS: Among 918 participants with OOP cost data, the average quarterly OOP cost was $34 (median: $5, IQR: $0-$25). Participants who were men, White, employed, completed college, and had commercial insurance had higher OOP costs. Higher OOP costs were not associated with lower PrEP persistence by Cox proportional hazards regression (adjusted hazard ratio = 1.00 per $50 increase, 95% CI = 0.97, 1.02). CONCLUSION: Among patients receiving care from these urban CHCs, OOP costs were low and did not undermine PrEP persistence.


Asunto(s)
Centros Comunitarios de Salud/economía , Infecciones por VIH/prevención & control , Gastos en Salud/estadística & datos numéricos , Hospitales Urbanos/economía , Cumplimiento de la Medicación/estadística & datos numéricos , Profilaxis Pre-Exposición/economía , Profilaxis Pre-Exposición/estadística & datos numéricos , Adolescente , Adulto , Niño , Centros Comunitarios de Salud/estadística & datos numéricos , Femenino , Hospitales Urbanos/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Estados Unidos , Adulto Joven
3.
Med Mal Infect ; 50(3): 252-256, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31387813

RESUMEN

OBJECTIVE: Staphylococcusaureus is involved in around 20% of nosocomial pneumonia cases. Vancomycin used to be the reference antibiotic in this indication, but new molecules have been commercialized, such as linezolid. Previous studies comparing vancomycin and linezolid were based on models. Comparing their real costs from a hospital perspective was needed. METHODS: We performed a bicentric retrospective analysis with a cost-minimization analysis. The hospital antibiotic acquisition costs were used, as well as the laboratory test and administration costs from the health insurance cost scale. The cost of each hospital stay was evaluated using the national cost scale per diagnosis related group (DRG), and was then weighted by the stay duration. RESULTS: Fifty-eight patients were included. All bacteria identified in pulmonary samples were S. aureus. The cost of nursing care per stay with linezolid was €234.10 (SD=91.50) vs. €381.70 (SD=184.70) with vancomycin (P=0.0029). The cost of laboratory tests for linezolid was €172.30 (SD=128.90) per stay vs. €330.70 (SD=198.40) for vancomycin (P=0.0005). The acquisition cost of linezolid per stay was not different from vancomycin based on the price of the generic drug (€54.92 [SD=20.54] vs. €40.30 [SD=22.70]). After weighting by the duration of stay observed, the mean cost per hospital stay was €47,411.50 for linezolid and €57,694.0 for vancomycin (NSD). CONCLUSION: These results, in favor of linezolid, support other former pharmacoeconomic study based on models. The mean cost per hospitalization stay was not statistically different between the two study groups, but a trend in favor of linezolid is emerging.


Asunto(s)
Infección Hospitalaria/tratamiento farmacológico , Linezolid/economía , Neumonía Estafilocócica/tratamiento farmacológico , Vancomicina/economía , Anciano , Costos y Análisis de Costo , Infección Hospitalaria/economía , Infección Hospitalaria/enfermería , Grupos Diagnósticos Relacionados , Costos de los Medicamentos , Economía de la Enfermería , Femenino , Francia , Hospitalización/economía , Hospitales Urbanos/economía , Humanos , Infusiones Intravenosas/economía , Tiempo de Internación/economía , Linezolid/administración & dosificación , Linezolid/uso terapéutico , Masculino , Persona de Mediana Edad , Neumonía Estafilocócica/economía , Neumonía Estafilocócica/enfermería , Estudios Retrospectivos , Staphylococcus aureus/efectos de los fármacos , Vancomicina/administración & dosificación , Vancomicina/uso terapéutico
4.
J Clin Hypertens (Greenwich) ; 21(12): 1831-1840, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31769184

RESUMEN

Mozambique has low levels of detection, treatment, and control of hypertension. However, data on target organ damage and clinical outcomes are lacking. The authors aimed at characterizing the clinical profile, pattern of target organ damage, and short-term outcomes of patients referred to a first referral urban hospital in a low-income setting in Africa. We conducted a prospective descriptive cohort study from February 2016 to May 2017 in Maputo, Mozambique. Adult patients with systolic and diastolic blood pressure ≥180 mm Hg and/or ≥110 mm Hg, respectively, or any systolic blood pressure above 140 mm Hg and/or diastolic blood pressure above 90 mm Hg in the presence of target organ damage (with or without antihypertensive treatment) were submitted to detailed physical examination, funduscopy, laboratory profile, electrocardiography, and echocardiography. Six months after the occurrence of complications (stroke, heart failure, and renal failure), hospital admission and death were assessed. Overall, 116 hypertensive patients were recruited (mean age 57.5 ± 12.8 years old; 111[95.7%] black; 81[70%] female) of which 79 had severe hypertension. The baseline mean values recorded for systolic and diastolic blood pressure were 192.3 ± 23.6 and 104.2 ± 15.2 mm Hg, respectively. Most patients (93; 80.2%) were on antihypertensive treatment. Patients' risk profile revealed dyslipidemia, obesity, and diabetes in 59(54.1%), 48(42.5%), and 23(19.8%), respectively. Target organ damage was found in 111 patients. The commonest being left atrial enlargement 91(84.5%), left ventricular hypertrophy 57(50.4%), hypertensive retinopathy 30(26.3%), and chronic kidney disease 27(23.3%). Major events during 6-month follow-up were hospitalizations in 10.3% and death in 8.6% of the patients. Worsening of target organ damage occurred in 10 patients: four stroke, two heart failure, and four renal damage. Patients with severe hypertension and target organ damage were young with high-risk profile, low hypertension control, and high occurrence of complications during short-term follow-up. Efforts to improve high blood pressure control are needed to reduce premature mortality in this highly endemic poor setting.


Asunto(s)
Presión Sanguínea/efectos de los fármacos , Recursos en Salud/provisión & distribución , Hospitales Urbanos/economía , Hipertensión/complicaciones , Adulto , Anciano , Antihipertensivos/uso terapéutico , Diástole/efectos de los fármacos , Femenino , Estudios de Seguimiento , Recursos en Salud/tendencias , Insuficiencia Cardíaca/epidemiología , Hospitalización , Hospitales Urbanos/estadística & datos numéricos , Humanos , Hipertensión/tratamiento farmacológico , Hipertensión/epidemiología , Retinopatía Hipertensiva/epidemiología , Hipertrofia Ventricular Izquierda/epidemiología , Masculino , Persona de Mediana Edad , Mozambique/epidemiología , Evaluación de Resultado en la Atención de Salud , Estudios Prospectivos , Insuficiencia Renal/epidemiología , Accidente Cerebrovascular/epidemiología , Sístole/efectos de los fármacos
5.
Biomedica ; 39(s1): 35-49, 2019 05 01.
Artículo en Inglés, Español | MEDLINE | ID: mdl-31529847

RESUMEN

Introduction: Urinary tract infections are very frequent in the hospital environment and given the emergence of antimicrobial resistance, they have made care processes more complex and have placed additional pressure on available healthcare resources. Objective: To describe and compare excess direct medical costs of urinary tract infections due to Klebsiella pneumoniae, Enterobacter cloacae and Pseudomonas aeruginosa resistant to beta-lactams. Materials and methods: A cohort study was conducted in a third level hospital in Medellín, Colombia, from October, 2014, to September, 2015. It included patients with urinary tract infections caused by beta-lactam-susceptible bacteria, third and fourth generation cephalosporin-resistant, as well as carbapenem-resistant. Costs were analyzed from the perspective of the health system. Clinical-epidemiological information was obtained from medical records and the costs were calculated using standard tariff manuals. Excess costs were estimated with multivariate analyses. Results: We included 141 patients: 55 (39%) were sensitive to beta-lactams, 54 (38.3%) were resistant to cephalosporins and 32 (22.7%) to carbapenems. The excess total adjusted costs of patients with urinary tract infections due to cephalosporin- and carbapenem-resistant bacteria were US$ 193 (95% confidence interval (CI): US$ -347-734) and US$ 633 (95% CI: US$ -50-1316), respectively, compared to the group of patients with beta-lactam sensitive urinary tract infections. The differences were mainly found in the use of broad-spectrum antibiotics such as meropenem, colistin, and fosfomycin. Conclusion: Our results show a substantial increase in the direct medical costs of patients with urinary tract infections caused by beta-lactam-resistant Gram-negative bacilli (cephalosporins and carbapenems). This situation is of particular concern in endemic countries such as Colombia, where the high frequencies of urinary tract infections and the resistance to beta-lactam antibiotics can generate a greater economic impact on the health sector.


Introducción. Las infecciones del tracto urinario son muy frecuentes en el ámbito hospitalario. Debido a la aparición de la resistencia antimicrobiana, la complejidad de los procesos de atención ha aumentado y, con ello, la demanda de recursos. Objetivo. Describir y comparar el exceso de los costos médicos directos de las infecciones del tracto urinario por Klebsiella pneumoniae, Enterobacter cloacae y Pseudomonas aeruginosa resistentes a betalactámicos. Materiales y métodos. Se llevó a cabo un estudio de cohorte en una institución de tercer nivel de Medellín, Colombia, entre octubre del 2014 y septiembre del 2015. Se incluyeron los pacientes con infección urinaria, unos por bacterias sensibles a los antibióticos betalactámicos, y otros por bacterias resistentes a las cefalosporinas de tercera y cuarta generación y a los antibióticos carbapenémicos. Los costos se analizaron desde la perspectiva del sistema de salud. La información clínico-epidemiológica se obtuvo de las historias clínicas y los costos se calcularon utilizando los manuales tarifarios estándar. El exceso de costos se estimó mediante análisis multivariados. Resultados. Se incluyeron 141 pacientes con infección urinaria: 55 (39 %) por bacterias sensibles a los betalactámicos, 54 (38,3 %) por bacterias resistentes a las cefalosporinas y 32 (22,7 %) por bacterias resistentes a los carbapenémicos. El exceso de costos totales ajustado de los 86 pacientes con infecciones del tracto urinario por bacterias resistentes a las cefalosporinas y a los carbapenémicos, fue de USD$ 193 (IC95% -347 a 734) y USD$ 633 (IC95% -50 a 1.316), respectivamente comparados con el grupo de 55 pacientes por bacterias sensibles a los betalactámicos. Las diferencias se presentaron principalmente en el uso de antibióticos de amplio espectro, como el meropenem, la colistina y la fosfomicina. Conclusión. Los resultados evidenciaron un incremento sustancial de los costos médicos directos de los pacientes con infecciones del tracto urinario por bacterias resistentes a las cefalosporinas o a los carbapenémicos. Esta situación genera especial preocupación en los países endémicos como Colombia, donde la alta frecuencia de infecciones del tracto urinario y de resistencia a los betalactámicos puede causar un mayor impacto económico en el sector de la salud.


Asunto(s)
Infección Hospitalaria/economía , Bacterias Gramnegativas/aislamiento & purificación , Gastos en Salud/estadística & datos numéricos , Hospitales Urbanos/economía , Centros de Atención Terciaria/economía , Infecciones Urinarias/economía , Resistencia betalactámica , Anciano , Anciano de 80 o más Años , Antibacterianos/economía , Carbapenémicos/farmacología , Cefalosporinas/farmacología , Estudios de Cohortes , Colombia , Infección Hospitalaria/microbiología , Diagnóstico por Imagen/economía , Farmacorresistencia Bacteriana Múltiple , Femenino , Bacterias Gramnegativas/efectos de los fármacos , Hospitalización/economía , Humanos , Masculino , Persona de Mediana Edad , Infecciones Urinarias/microbiología , beta-Lactamas/farmacología
6.
Biomédica (Bogotá) ; 39(supl.1): 35-49, mayo 2019. tab, graf
Artículo en Español | LILACS | ID: biblio-1011453

RESUMEN

Resumen Introducción. Las infecciones del tracto urinario son muy frecuentes en el ámbito hospitalario. Debido a la aparición de la resistencia antimicrobiana, la complejidad de los procesos de atención ha aumentado y, con ello, la demanda de recursos. Objetivo. Describir y comparar el exceso de los costos médicos directos de las infecciones del tracto urinario por Klebsiella pneumoniae, Enterobacter cloacae y Pseudomonas aeruginosa resistentes a betalactámicos. Materiales y métodos. Se llevó a cabo un estudio de cohorte en una institución de tercer nivel de Medellín, Colombia, entre octubre del 2014 y septiembre del 2015. Se incluyeron los pacientes con infección urinaria, unos por bacterias sensibles a los antibióticos betalactámicos, y otros por bacterias resistentes a las cefalosporinas de tercera y cuarta generación y a los antibióticos carbapenémicos. Los costos se analizaron desde la perspectiva del sistema de salud. La información clínico-epidemiológica se obtuvo de las historias clínicas y los costos se calcularon utilizando los manuales tarifarios estándar. El exceso de costos se estimó mediante análisis multivariados. Resultados. Se incluyeron 141 pacientes con infección urinaria: 55 (39 %) por bacterias sensibles a los betalactámicos, 54 (38,3 %) por bacterias resistentes a las cefalosporinas y 32 (22,7 %) por bacterias resistentes a los carbapenémicos. El exceso de costos totales ajustado de los 86 pacientes con infecciones del tracto urinario por bacterias resistentes a las cefalosporinas y a los carbapenémicos, fue de USD$ 193 (IC95% -347 a 734) y USD$ 633 (IC95% -50 a 1.316), respectivamente comparados con el grupo de 55 pacientes por bacterias sensibles a los betalactámicos. Las diferencias se presentaron principalmente en el uso de antibióticos de amplio espectro, como el meropenem, la colistina y la fosfomicina. Conclusión. Los resultados evidenciaron un incremento sustancial de los costos médicos directos de los pacientes con infecciones del tracto urinario por bacterias resistentes a las cefalosporinas o a los carbapenémicos. Esta situación genera especial preocupación en los países endémicos como Colombia, donde la alta frecuencia de infecciones del tracto urinario y de resistencia a los betalactámicos puede causar un mayor impacto económico en el sector de la salud.


Abstract Introduction: Urinary tract infections are very frequent in the hospital environment and given the emergence of antimicrobial resistance, they have made care processes more complex and have placed additional pressure on available healthcare resources. Objective: To describe and compare excess direct medical costs of urinary tract infections due to Klebsiella pneumoniae, Enterobacter cloacae and Pseudomonas aeruginosa resistant to beta-lactams. Materials and methods: A cohort study was conducted in a third level hospital in Medellín, Colombia, from October, 2014, to September, 2015. It included patients with urinary tract infections caused by beta-lactam-susceptible bacteria, third and fourth generation cephalosporin-resistant, as well as carbapenem-resistant. Costs were analyzed from the perspective of the health system. Clinical-epidemiological information was obtained from medical records and the costs were calculated using standard tariff manuals. Excess costs were estimated with multivariate analyses. Results: We included 141 patients: 55 (39%) were sensitive to beta-lactams, 54 (38.3%) were resistant to cephalosporins and 32 (22.7%) to carbapenems. The excess total adjusted costs of patients with urinary tract infections due to cephalosporin- and carbapenem-resistant bacteria were US$ 193 (95% confidence interval (CI): US$ -347-734) and US$ 633 (95% CI: US$ -50-1316), respectively, compared to the group of patients with beta-lactam sensitive urinary tract infections. The differences were mainly found in the use of broad-spectrum antibiotics such as meropenem, colistin, and fosfomycin. Conclusion: Our results show a substantial increase in the direct medical costs of patients with urinary tract infections caused by beta-lactam-resistant Gram-negative bacilli (cephalosporins and carbapenems). This situation is of particular concern in endemic countries such as Colombia, where the high frequencies of urinary tract infections and the resistance to beta-lactam antibiotics can generate a greater economic impact on the health sector.


Asunto(s)
Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infecciones Urinarias/economía , Hospitales Urbanos/economía , Infección Hospitalaria/economía , Gastos en Salud/estadística & datos numéricos , Resistencia betalactámica , Centros de Atención Terciaria/economía , Bacterias Gramnegativas/aislamiento & purificación , Infecciones Urinarias/microbiología , Diagnóstico por Imagen/economía , Carbapenémicos/farmacología , Cefalosporinas/farmacología , Infección Hospitalaria/microbiología , Estudios de Cohortes , Colombia , Farmacorresistencia Bacteriana Múltiple , beta-Lactamas/farmacología , Bacterias Gramnegativas/efectos de los fármacos , Hospitalización/economía , Antibacterianos/economía
7.
J Bone Joint Surg Am ; 101(2): 152-159, 2019 Jan 16.
Artículo en Inglés | MEDLINE | ID: mdl-30653045

RESUMEN

BACKGROUND: Despite increasing interest in total joint arthroplasty registries, evidence of the impact of physician-level performance on the value of care provided to patients undergoing hip and knee arthroplasty is lacking. The purpose of this study was to examine the effectiveness of an unblinded orthopaedic surgeon-specific value scorecard in improving patient outcomes and reducing hospital costs. METHODS: We retrospectively analyzed patient outcomes and hospital costs associated with total joint arthroplasties before and 9 months after the introduction of a Surgeon Value Scorecard at an urban tertiary care center. From August 2016 to May 2017, orthopaedic surgeons received an unblinded monthly Surgeon Value Scorecard summarizing a rolling 6-month view of results by surgeon for patients attributed to Diagnosis Related Group 470 (major lower-extremity arthroplasty without comorbidity or complication). Prior to implementation, surgeons were educated on the scorecard and participated in the development of a document outlining the definition and calculation of included metrics. Scorecard metrics were grouped into 5 categories: patient demographic characteristics, patient outcomes (for example, length of stay, discharge disposition, readmissions), patient experience, financial, and operational (for example, operative times). Financial (cost) measures and patient outcomes were selected as the key performance indicators analyzed in this study. Continuous variables were analyzed using the t test when a normal distribution was assumed and using Mann-Whitney tests when a non-normal distribution was assumed. Categorical variables were compared using chi-square tests. Significance was defined as p < 0.05. RESULTS: After 9 months of unblinded Surgeon Value Scorecard distribution, the mean total costs for total joint arthroplasties decreased by 8.7%, from $17,996 to $16,426 (p < 0.001). The mean total direct variable costs decreased by 17.1% from $10,945 to $9,070 (p < 0.001), and implant costs decreased by 5.3% (p < 0.001). Length of stay also decreased by 0.2 day to 1.7 days (p < 0.001), and, although there was improvement in the home-discharge rate, 30-day readmission rate, and 90-day readmission rate, the differences were not significant (p > 0.05). CONCLUSIONS: The implementation of a surgeon-specific value scorecard for lower-extremity joint arthroplasties was associated with reduced total and direct variable hospital costs, reduced implant costs, decreased variation in costs, and reduced postoperative length of stay, without compromising clinical outcomes. CLINICAL RELEVANCE: Sharing unblinded clinical and financial outcomes with surgeons may promote a culture of shared accountability and may empower surgeons to improve value-based decision-making in care delivery.


Asunto(s)
Artroplastia de Reemplazo de Cadera/economía , Artroplastia de Reemplazo de Rodilla/economía , Equipos y Suministros de Hospitales/economía , Costos de Hospital , Ahorro de Costo , Costos y Análisis de Costo , Femenino , Hospitales Urbanos/economía , Humanos , Tiempo de Internación/economía , Masculino , Persona de Mediana Edad , Quirófanos/economía , Estudios Retrospectivos
8.
Am J Surg ; 217(6): 1102-1106, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30389118

RESUMEN

BACKGROUND: The purpose of our study was to assess the outcomes and costs of appendectomies performed at rural and urban hospitals. METHODS: The National Inpatient Sample (2001-2012) was queried for appendectomies at urban and rural hospitals. Outcomes (disease severity, laparoscopy, complications, length of stay (LOS), and cost) were analyzed. RESULTS: Rural patients were more likely to be older, male, white, and have Medicaid or no insurance. Rural hospitals were associated with higher negative appendectomy rates (OR = 1.26,95%CI = 1.18-1.34,p < 0.01), less laparoscopy use (OR = 0.65,95%CI = 0.58-0.72,p < 0.01), and slightly shorter LOS (OR = 0.98,95%CI = 0.97-0.99,p < 0.01). There was no consistent association with perforated appendicitis and no difference in complications or costs after adjusting for hospital volume. Yearly trends showed a significant increase in the cases utilizing laparoscopy each year at rural hospitals. CONCLUSIONS: Rural appendectomies are associated with increased negative appendectomy rates and less laparoscopy use with no difference in complications or costs compared to urban hospitals.


Asunto(s)
Apendicectomía/economía , Apendicitis/cirugía , Costos de Hospital/estadística & datos numéricos , Hospitales Rurales/economía , Hospitales Urbanos/economía , Adulto , Anciano , Apendicitis/economía , Bases de Datos Factuales , Femenino , Hospitales Rurales/estadística & datos numéricos , Hospitales Urbanos/estadística & datos numéricos , Humanos , Laparoscopía/economía , Laparoscopía/estadística & datos numéricos , Tiempo de Internación/economía , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/economía , Complicaciones Posoperatorias/epidemiología , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Estados Unidos
9.
Int J Health Plann Manage ; 34(2): 553-571, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30549091

RESUMEN

The main aim of the article is to analyze the occurrence of agglomeration effect in the hospital sector on the basis of financial performance. The considerations are made on the example of hospitals in Poland-the country that survived the latest economic crisis relatively well, usually generating positive values of GDP, but where still there is an ongoing discussion on the final shape of healthcare financing model. The article is based on the assumption that there occur significant differences in financial performance between hospitals according to their location. The research hypothesis is as follows: Hospitals operating in big cities are featured by better financial condition than their counterparts operating in smaller towns. To verify the hypothesis, the methods of financial analysis and statistical hypothesis testing are used. As it is emphasized in the article, the assumption is true and the hypothesis can be verified positively.


Asunto(s)
Economía Hospitalaria/organización & administración , Hospitales Rurales/economía , Hospitales Urbanos/economía , Economía Hospitalaria/estadística & datos numéricos , Geografía/economía , Geografía/estadística & datos numéricos , Financiación de la Atención de la Salud , Hospitales Rurales/estadística & datos numéricos , Hospitales Urbanos/estadística & datos numéricos , Humanos , Polonia
10.
BMJ Open ; 8(11): e022090, 2018 11 25.
Artículo en Inglés | MEDLINE | ID: mdl-30478107

RESUMEN

OBJECTIVE: Disparities in treatment outcomes for traumatic injury are an important concern for care providers and policy makers. Factors that may influence these disparities include differences in risk exposure based on neighbourhood of residence and differences in quality of care between hospitals in different areas. This study examines geographical disparities within a single region: the Detroit metropolitan area. DESIGN: Data on all trauma admissions between 2006 and 2014 were obtained from the Michigan State Inpatient Database. Admissions were grouped by patient neighbourhood of residence and admitting hospital. Generalised linear mixed modelling procedures were used to determine the extent of shared variance based on these two levels of categorisation on three outcomes. Patients with trauma due to common mechanisms (falls, firearms and motor vehicle traffic) were examined as additional subgroups. SETTING: 66 hospitals admitting patients for traumatic injury in the Detroit metropolitan area during the period from 2006 to 2014. PARTICIPANTS: 404 675 adult patients admitted for treatment of traumatic injury. OUTCOME MEASURES: In-hospital mortality, length of stay and hospital charges. RESULTS: Intraclass correlation coefficients indicated that there was substantial shared variance in outcomes based on hospital, but not based on neighbourhood of residence. Among all injury types, hospital-level differences accounted for 12.5% of variance in mortality risk, 28.5% of variance in length of stay and 32.2% of variance in hospital charges. Adjusting the results for patient age, injury severity, mechanism and comorbidities did not result in significant reduction in the estimated variance at the hospital level. CONCLUSIONS: Based on these data, geographical disparities in trauma treatment outcomes were more strongly attributable to differences in access to quality hospital care than to risk factors in the neighbourhood environment. Transfer of high-risk cases to hospitals with greater institutional experience in the relevant area may help address mortality disparities in particular.


Asunto(s)
Disparidades en Atención de Salud/estadística & datos numéricos , Hospitales Urbanos/estadística & datos numéricos , Características de la Residencia/estadística & datos numéricos , Heridas y Lesiones/terapia , Accidentes por Caídas/estadística & datos numéricos , Accidentes de Tránsito/estadística & datos numéricos , Factores de Edad , Anciano , Estudios Transversales , Femenino , Disparidades en Atención de Salud/economía , Precios de Hospital/estadística & datos numéricos , Mortalidad Hospitalaria , Hospitales Urbanos/economía , Humanos , Puntaje de Gravedad del Traumatismo , Tiempo de Internación/estadística & datos numéricos , Modelos Lineales , Masculino , Michigan , Persona de Mediana Edad , Resultado del Tratamiento , Heridas y Lesiones/economía , Heridas por Arma de Fuego/terapia
11.
Am Surg ; 84(8): 1368-1375, 2018 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-30185318

RESUMEN

Level I trauma centers serve as a community resource, with most centers using an inclusive transfer policy that may result in overtriage. The financial burden this imparts on an urban trauma system has not been well examined. We sought to examine the incidence of secondary overtriage (SOT) at an urban Level I trauma center. This was a retrospective study from an urban Level I trauma center examining patients admitted as trauma transfers (TT) from 2010 to 2014. SOT was defined as patients not meeting the "Orange Book" transfer criteria and who had a length of stay of <48 hours. Average ED and transport charges were calculated for total transfer charges. A total of 2397 TT were treated. The number of TT increased over the study interval. The mean age of TT was 59.7 years (SD ± 26.4 years); patients were predominantly male (59.2%), white (83.2%), with at least one comorbidity (71.5%). Blunt trauma accounted for 96.8 per cent of admissions with a median Injury Severity Score of nine (IQR: 5-16). Predominant injuries were isolated closed head trauma (61.4%), skin/soft tissue injury (18.9%), and spinal injury (17.6%). SOT was 48.2 per cent and increased yearly (P < 0.001). The median trauma center charge for SOT was ($27,072; IQR: $20,089-34,087), whereas ED charges were ($40,440; IQR: $26,150-65,125), resulting in a total cost of $67,512/patient. A liberal TT policy results in a high SOT rate adding significant unnecessary costs to the health-care system. Efforts to establish transfer guidelines may allow for significant cost savings without compromising care.


Asunto(s)
Hospitales Urbanos/economía , Transferencia de Pacientes/economía , Centros Traumatológicos/economía , Triaje/economía , Heridas y Lesiones/economía , Adulto , Anciano , Anciano de 80 o más Años , Costos y Análisis de Costo , Femenino , Hospitalización/economía , Humanos , Puntaje de Gravedad del Traumatismo , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Heridas y Lesiones/diagnóstico , Heridas y Lesiones/terapia
12.
Med Care ; 56(8): 686-692, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29912839

RESUMEN

BACKGROUND: Accountable Care Organizations in the Medicare Shared Savings Program (MSSP) have financial incentives to reduce the cost and improve the quality of care delivered to Medicare beneficiaries that they serve. However, previous research about the impact of the MSSP on readmissions is limited and mixed. OBJECTIVE: To examine the association between hospital participation in the MSSP during the 2012-2013 period and reductions in 30-day risk-standardized readmission rates for Medicare patients initially admitted for acute myocardial infarction, heart failure (HF), pneumonia, or any cause. RESEARCH DESIGN: Difference-in-differences estimation to compare the change in readmission rates for hospitals participating in the MSSP with that of other hospitals. SUBJECTS: Acute care hospitals that either participated in the MSSP or did not participate in any of Medicare Accountable Care Organization programs (for acute myocardial infarction, n=1631; for HF, n=1889; for pneumonia, n=1896; for any cause, n=2067). RESULTS: Compared with nonparticipating hospitals, MSSP-participating hospitals showed greater reductions in readmission rates for Medicare patients originally admitted for HF by 0.47 percentage points [95% confidence interval (CI), -0.76 to -0.17] and for pneumonia by 0.26 percentage points (95% CI, -0.49 to -0.03). MSSP-participating hospitals also showed more reductions in hospital-wide all-cause readmission by 0.10 percentage points (95% CI, -0.20 to 0.01), relative to nonparticipating hospitals during the first year of MSSP. CONCLUSIONS: MSSP-participating hospitals showed slightly greater reductions in readmissions during postimplementation years for Medicare patients initially admitted for HF or pneumonia, compared with other hospitals.


Asunto(s)
Organizaciones Responsables por la Atención/estadística & datos numéricos , Planes de Aranceles por Servicios/estadística & datos numéricos , Hospitales Urbanos/estadística & datos numéricos , Medicare/estadística & datos numéricos , Readmisión del Paciente/estadística & datos numéricos , Organizaciones Responsables por la Atención/economía , Planes de Aranceles por Servicios/economía , Femenino , Hospitales Urbanos/economía , Humanos , Masculino , Medicare/economía , Readmisión del Paciente/economía , Calidad de la Atención de Salud/organización & administración , Estados Unidos
13.
World J Surg ; 42(12): 3841-3848, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-29947983

RESUMEN

BACKGROUND: Cost of getting health services is a major concern in Bangladesh as well as in many other countries. A family has to bear more than half of the health care cost despite many facilities provided by the public hospitals. This out-of-pocket (OOP) expenditure drives many families under the poverty line. The aim of this study was to find out the exact cost incurred by the family for a surgical operation of their child in the public and private sectors in Bangladesh. METHODS: A cross-sectional study was conducted to find out the cost of child surgery in different settings of public and private hospitals in Chittagong division, Bangladesh. Cost of herniotomy was then compared across different settings. RESULTS: In this study, cost of operation in urban private hospitals was highest mostly due to surgeon and anesthetist fee. The cost was lowest in outreach programs as surgeon fee, anesthetist fee and accommodation cost was nil; food and transport cost was minimum. However, cost of accommodation, food, transport and medicine contributed significantly to OOP expenditure especially in tertiary-level public hospitals, in both indoor and day care settings, and also in private urban hospitals. CONCLUSIONS: Our study provides some insight into the OOP expenditure in different health care settings in Bangladesh. This study might be useful in developing a strategy to minimize the OOP expenditure in this country.


Asunto(s)
Gastos en Salud , Hospitales Privados/economía , Hospitales Públicos/economía , Hospitales Urbanos/economía , Procedimientos Quirúrgicos Operativos/economía , Centros de Atención Terciaria/economía , Anestesistas/economía , Bangladesh , Niño , Preescolar , Estudios Transversales , Honorarios y Precios , Femenino , Herniorrafia/economía , Humanos , Lactante , Recién Nacido , Masculino , Cirujanos/economía
14.
Reprod Health ; 15(1): 54, 2018 Mar 27.
Artículo en Inglés | MEDLINE | ID: mdl-29587802

RESUMEN

BACKGROUND: The disrespect and abuse of women during the process of childbirth is an emergent and global problem and only few studies have investigated this worrying issue. The objective of the present study was to describe the prevalence of disrespect and abuse of women during childbirth in Pelotas City, Brazil, and to investigate the factors involved. METHODS: This was a cross-sectional population-based study of women delivering members of the 2015 Pelotas birth cohort. Information relating to disrespect and abuse during childbirth was obtained by household interview 3 months after delivery. The information related to verbal and physical abuse, denial of care and invasive and/or inappropriate procedures. Poisson regression was used to evaluate the factors associated with one or more, and two or more, types of disrespectful treatment or abuse. RESULTS: A total of 4275 women took part in a perinatal study. During the three-month follow-up, we interviewed 4087 biological mothers with regards to disrespect and abuse. Approximately 10% of women reported having experienced verbal abuse, 6% denial of care, 6% undesirable or inappropriate procedures and 5% physical abuse. At least one type of disrespect or abuse was reported by 18.3% of mothers (95% confidence interval [CI]: 17.2-19.5); and at least two types by 5.1% (95% CI: 4.4-5.8). Women relying on the public health sector, and those whose childbirths were via cesarean section with previous labor, had the highest risk, with approximately a three- and two-fold increase in risk, respectively. CONCLUSIONS: Our study showed that the occurrence of disrespect and abuse during childbirth was high and mostly associated with payment by the public sector and labor before delivery. The efforts made by civil society, governments and international organizations are not sufficient to restrain institutional violence against women during childbirth. To eradicate this problem, it is essential to 1) implement policies and actions specific for this type of violence and 2) formulate laws to promote the equality of rights between women and men, with particular emphasis on the economic rights of women and the promotion of gender equality in terms of access to jobs and education.


Asunto(s)
Violencia de Género , Acoso no Sexual , Hospitales Urbanos , Parto , Personeidad , Relaciones Profesional-Paciente , Estrés Psicológico/etiología , Adulto , Brasil/epidemiología , Estudios de Cohortes , Estudios Transversales , Femenino , Estudios de Seguimiento , Violencia de Género/economía , Violencia de Género/ética , Violencia de Género/etnología , Violencia de Género/psicología , Acoso no Sexual/economía , Acoso no Sexual/ética , Acoso no Sexual/etnología , Acoso no Sexual/psicología , Precios de Hospital , Hospitales Urbanos/economía , Hospitales Urbanos/ética , Humanos , Incidencia , Errores Médicos/economía , Errores Médicos/ética , Errores Médicos/prevención & control , Errores Médicos/psicología , Evaluación de Necesidades , Parto/etnología , Parto/psicología , Embarazo , Prevalencia , Relaciones Profesional-Paciente/ética , Negativa al Tratamiento/ética , Riesgo , Autoinforme , Estrés Psicológico/epidemiología , Estrés Psicológico/etnología , Estrés Psicológico/psicología , Recursos Humanos
15.
Pediatrics ; 141(2)2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29367203

RESUMEN

BACKGROUND: Standardized pediatric asthma care has been shown to improve measures in specific hospital areas, but to our knowledge, the implementation of an asthma clinical practice guideline (CPG) has not been demonstrated to be associated with improved hospital-wide outcomes. We sought to implement and refine a pediatric asthma CPG to improve outcomes and throughput for the emergency department (ED), inpatient care, and the ICU. METHODS: An urban, quaternary-care children's hospital developed and implemented an evidence-based, pediatric asthma CPG to standardize care from ED arrival through discharge for all primary diagnosis asthma encounters for patients ≥2 years old without a complex chronic condition. Primary outcomes included ED and inpatient length of stay (LOS), percent ED encounters requiring admission, percent admissions requiring ICU care, and total charges. Balancing measures included the number of asthma discharges between all-cause 30-day readmissions after asthma discharges and asthma relapse within 72 hours. Statistical process control charts were used to monitor and analyze outcomes. RESULTS: Analyses included 3650 and 3467 encounters 2 years pre- and postimplementation, respectively. Postimplementation, reductions were seen in ED LOS for treat-and-release patients (3.9 hours vs 3.3 hours), hospital LOS (1.5 days vs 1.3 days), ED encounters requiring admission (23.5% vs 18.8%), admissions requiring ICU (23.0% vs 13.2%), and total charges ($4457 vs $3651). Guideline implementation was not associated with changes in balancing measures. CONCLUSIONS: The hospital-wide standardization of a pediatric asthma CPG across hospital units can safely reduce overall hospital resource intensity by reducing LOS, admissions, ICU services, and charges.


Asunto(s)
Asma/terapia , Hospitales Pediátricos/normas , Mejoramiento de la Calidad , Antiasmáticos/uso terapéutico , Antiinflamatorios/uso terapéutico , Asma/tratamiento farmacológico , Niño , Cuidados Críticos/economía , Cuidados Críticos/normas , Dexametasona/uso terapéutico , Servicio de Urgencia en Hospital/economía , Servicio de Urgencia en Hospital/normas , Medicina Basada en la Evidencia , Adhesión a Directriz , Precios de Hospital , Hospitalización/economía , Hospitales Pediátricos/economía , Hospitales Urbanos/economía , Hospitales Urbanos/normas , Humanos , Tiempo de Internación/economía
16.
J Int Assoc Provid AIDS Care ; 16(6): 527-530, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-29076395

RESUMEN

We undertook a retrospective cohort study of patients with a positive HIV test in the emergency department who were then linked to care. Inpatient, outpatient, and emergency costs were collected for the first 2 years after HIV diagnosis. Fifty-six patients met the inclusion criteria; they were predominantly uninsured (73%) and African American (89%). The median total cost for a newly diagnosed patient over the first 2 years was US$36 808, driven predominantly by outpatient costs of US$17 512. Median inpatient and total costs were significantly different between the lowest (<200 cells/mm3) and highest (>499 cells/mm3) CD4 count categories (US$21 878 vs US$6607, P <.05; US$61 378 vs US$18 837, P <.05, respectively). Total costs were significantly different between viral load categories <100 000 HIV-RNA copies/mL and ≥100 000 HIV-RNA copies/mL (US$28 219 vs US$49 482, P <.05). Costs were significantly lower among patients diagnosed earlier in their disease. Decreased cost is another factor supporting early diagnosis and linkage to care for patients with HIV.


Asunto(s)
Atención Ambulatoria/economía , Diagnóstico Precoz , Servicio de Urgencia en Hospital/economía , Infecciones por VIH/diagnóstico , Costos de la Atención en Salud , Hospitalización/economía , Adulto , Recuento de Linfocito CD4 , Organizaciones de Beneficencia , Estudios de Cohortes , Análisis Costo-Beneficio , Servicio de Urgencia en Hospital/estadística & datos numéricos , Femenino , Infecciones por VIH/sangre , Infecciones por VIH/terapia , Hospitales Urbanos/economía , Humanos , Masculino , Persona de Mediana Edad , Nueva Orleans , ARN Viral/sangre , Estudios Retrospectivos , Carga Viral
17.
BMC Nephrol ; 18(1): 279, 2017 Sep 02.
Artículo en Inglés | MEDLINE | ID: mdl-28865432

RESUMEN

BACKGROUND: Despite improved health outcomes associated with arteriovenous fistulas, 80% of Americans initiate hemodialysis using a catheter, influenced by low socioeconomic status among other factors. Risk factors for incident catheter use in safety-net populations are unknown. Our objective was to identify factors associated with incident catheter use among hemodialysis patients at one safety-net hospital, with a goal of informing fistula placement initiatives targeted at safety-net populations more generally. METHODS: We performed a retrospective review of all incident hemodialysis patients at a single urban safety-net hospital from January 1, 2010 - December 31, 2015 (n = 241), as well as semi-structured interviews with a multi-lingual convenience sample of patients (n = 10) from this cohort. The primary outcome was incident vascular access modality. Multivariable logistic regression was used to identify factors associated with incident catheter use. Interview transcripts were coded using a directed content analysis framework based on a model describing barriers to healthcare access. RESULTS: Subjects were 61.8% male, racially/ethnically diverse (19.5% white, 29.5% black, 28.6% Hispanic, 17.4% Asian), with a mean age of 52.4 years. Eighty-eight percent initiated hemodialysis using a catheter. In multivariable analysis, longer duration of nephrology care was associated with decreased catheter use (>12 months vs. 0-6 months: adjusted Odds Ratio [aOR] 0.07, 95% CI 0.02-0.23, p < 0.001), whereas uninsured status increased odds of catheter use (aOR 3.96, 1.23-12.76, p = 0.02). There was a decrease in catheter use after vascular surgery services became available in-hospital (OR 0.40, 95% CI 0.16-0.98, p = 0.04), however this association was not significant in multivariable analysis (aOR 0.48, 0.17-1.36, p = 0.17). During interviews, patients cited emotional responses to disease, lack of social and financial resources, and limited health knowledge as barriers to obtaining fistula surgery. CONCLUSIONS: The rate of catheter use in this urban safety-net population is above the national average. Access to health insurance, early referrals to nephrology, and provision of in-hospital vascular surgery should be prioritized in the safety-net. Additionally, services that support patients' emotional and learning needs may decrease delays in fistula placement.


Asunto(s)
Catéteres de Permanencia/tendencias , Hospitales Urbanos/tendencias , Diálisis Renal/tendencias , Proveedores de Redes de Seguridad/tendencias , Adulto , Anciano , Anciano de 80 o más Años , Catéteres de Permanencia/efectos adversos , Catéteres de Permanencia/economía , Estudios de Cohortes , Femenino , Hospitales Urbanos/economía , Humanos , Seguro de Salud/economía , Seguro de Salud/tendencias , Masculino , Pacientes no Asegurados , Persona de Mediana Edad , Diálisis Renal/efectos adversos , Diálisis Renal/economía , Estudios Retrospectivos , Proveedores de Redes de Seguridad/economía , Adulto Joven
18.
J Manag Care Spec Pharm ; 23(7): 781-788, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28650248

RESUMEN

BACKGROUND: In 2011, fee-for-service patients with both Medicare and Medicaid (dual eligible) sustained $319.5 billion in health care costs. OBJECTIVE: To describe the emergency department (ED) use and hospital admissions of adult dual eligible patients aged under 65 years who used an urban safety net hospital. METHODS: This was a retrospective database analysis of patients aged between 18 and 65 years with Medicare and Medicaid, who used an urban safety net academic health center between January 1, 2011, and December 31, 2011. We compared patients with and without behavioral health illness. The main outcome measures were hospital admission and ED use. Chi-square and Wilcoxon rank-sum tests were used for descriptive statistics on categorical and continuous variables, respectively. Greedy propensity score matching was used to control for confounding factors. Rate ratios (RR) and 95% confidence intervals (CI) were determined after matching and after adjusting for those variables that remained significantly different after matching. RESULTS: In 2011, 10% of all fee-for-service dual eligible patients aged less than 65 years in Massachusetts were seen at Boston Medical Center. Data before propensity score matching showed significant differences in age, sex, race/ethnicity, marital status, education, employment, physical comorbidities, and Charlson Comorbidity Index score between patients with and without behavioral health illness. Analysis after propensity score matching found significant differences in sex, Hispanic race, and other education and employment status. Compared with patients without behavioral health illness, patients with behavioral health illness had a higher RR for hospital admissions (RR = 2.07; 95% CI = 1.81-2.38; P < 0.001) and ED use (RR = 1.61; 95% CI = 1.46-1.77; P < 0.001). Results were robust after adjusting for characteristics that remained statistically significantly different after propensity score matching. CONCLUSIONS: Adult dual eligible patients aged less than 65 years with behavioral health illness in the Medicaid fee-for-service plan had significantly higher rates of hospital admission and ED use compared with dual eligible patients without behavioral health illness at the largest urban safety net medical center in New England. Safety net hospitals care for a large proportion of dual eligible patients with behavioral health illness. Further research is needed to elucidate the systems-related and patient-centered factors contributing to the utilization behaviors of this patient population. DISCLOSURES: This research was funded in part by a National Research Service Award (T3HP10028-14-01). The authors have no conflicts of interests to disclose. Cancino had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design were contributed by Cancino, Jack, and Burgess, with assistance from Cremieux. Cancino and Cremieux took the lead in data collection, along with Jack and Burgess, and data interpretation was performed by Jarvis, Cummings, and Cooper, along with the other authors. The manuscript was written primarily by Cancino, along with Jack and Burgess, and revised primarily by Cancino, along with the other authors.


Asunto(s)
Planes de Aranceles por Servicios/tendencias , Medicaid/tendencias , Medicare/tendencias , Aceptación de la Atención de Salud , Problema de Conducta , Proveedores de Redes de Seguridad/tendencias , Adulto , Estudios Transversales , Planes de Aranceles por Servicios/economía , Femenino , Hospitales Urbanos/economía , Hospitales Urbanos/tendencias , Humanos , Masculino , Medicaid/economía , Medicare/economía , Persona de Mediana Edad , Estudios Retrospectivos , Proveedores de Redes de Seguridad/economía , Estados Unidos/epidemiología
19.
J Nurs Adm ; 47(6): 313-319, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28509721

RESUMEN

BACKGROUND: The Centers for Medicare and Medicaid Services Innovation Center introduced the Bundled Payments for Care Improvement (BPCI) initiative in 2011 as 1 strategy to encourage healthcare organizations and clinicians to improve healthcare delivery for patients, both when they are in the hospital and after they are discharged. Mercy Health Saint Mary's, a large urban academic medical center, engaged in BPCI primarily with a group of medical diagnosis-related groups (DRGs). OBJECTIVES: In this article, we describe our experience creating a system of response for the diverse people and diagnoses that fall into the medical DRG bundles and specifically identify organizational factors for enabling successful implementation of bundled payments. RESULTS: Our experience suggests that interprofessional collaboration enabled program success. CONCLUSIONS: Although still in its early phases, observations from our program's strategies and tactics may provide potential insights for organizations considering engagement in the BPCI initiative.


Asunto(s)
Ahorro de Costo/economía , Atención a la Salud/economía , Medicaid/economía , Medicare/economía , Paquetes de Atención al Paciente/economía , Mejoramiento de la Calidad/economía , Centros Médicos Académicos/economía , Grupos Diagnósticos Relacionados , Hospitales Urbanos/economía , Humanos , Estados Unidos
20.
J Bone Joint Surg Am ; 99(1): e2, 2017 Jan 04.
Artículo en Inglés | MEDLINE | ID: mdl-28060238

RESUMEN

The Centers for Medicare & Medicaid Services (CMS) implemented the Bundled Payments for Care Improvement (BPCI) initiative in 2011. Through BPCI, organizations enlisted into payment agreements that include both performance and financial accountability for episodes of care. To succeed, BPCI requires quality maintenance and care delivery at lower costs. This necessitates physicians and hospitals to merge interests. Orthopaedic surgeons must assume leadership roles in cost containment, surgical safety, and quality assurance to deliver cost-effective care. Because most orthopaedic surgeons practice independently and are not employed by hospitals, models of physician-hospital alignment (e.g., physician-hospital organizations) or contracted gainsharing arrangements between practices and hospitals may be necessary for successful bundled pricing. Under BPCI, hospitals, surgeons, or third parties share rewards but assume risks for the bundle.For patients, cost savings must be associated with maintenance or improvement in quality metrics. However, the definition of quality can vary, as can the rewards for processes and outcomes. Risk stratification for potential complications should be considered in bundled pricing agreements to prevent the exclusion of patients with substantial comorbidities and higher care costs (e.g., hip fractures treated with prostheses). Bundled pricing depends on economies of scale for success; smaller institutions must be cautious, as 1 costly patient could substantially impact the finances of its entire program. CMS recommends a minimum of 100 to 200 cases yearly. We also suggest that participants utilize technologies to maximize efficiency and provide the best possible environment for implementation of bundled payments. Substantial investment in infrastructure is required to develop programs to improve coordination of care, manage quality data, and distribute payments. Smaller institutions may have difficulty devoting resources to these infrastructural changes, although changes may be implemented more thoroughly once initiated. Herein, we discuss our early total joint arthroplasty BPCI experience at our tertiary-care academic medical center.


Asunto(s)
Ahorro de Costo/economía , Paquetes de Atención al Paciente/economía , Mejoramiento de la Calidad/economía , Reembolso de Incentivo/economía , Ahorro de Costo/normas , Atención a la Salud/economía , Atención a la Salud/normas , Hospitales Urbanos/economía , Hospitales Urbanos/normas , Humanos , Medicare/economía , Readmisión del Paciente/economía , Readmisión del Paciente/normas , Centros de Atención Terciaria/economía , Centros de Atención Terciaria/normas , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...